Related News Articles

07/24/2025

1 in 4 Americans provide ongoing, complex care; report finds they endure poor health, financial strain and isolation.

07/21/2025

They also offer people the power to take control of their health.

07/17/2025

Cognitive Maladaptation Hypothesis—a model suggesting link from untreated hearing loss and how it can contribute to cognitive impairment.

07/17/2025

More than half of Michigan’s adults age 50 and older have ever used artificial intelligence technology.

06/21/2025

Nuance Audio is a new option for people who resist traditional aids, from the company that makes Ray-Bans and operates LensCrafters.

You are here

Pear Therapeutics licenses voice biomarkers for dementia and psychiatric disorders

 To improve treatment for patients with illnesses ranging from Alzheimer’s to insomnia and substance use disorder.

Tuesday, January 7, 2020

Categories

login account